Although the existence of autohemagglutinins in certain forms of adult human acquired hemolytic anemia is a well established phenomenon (1), their exact role in the pathogenesis of the disease process remains somewhat vague. The recent reports of Mohn, Lambert, Bowman, and Brason (2-4) have described the production of autoantibodies to human red cell antigens as a result of passive immunization of D (Rh0) positive volunteers with human plasma containing incomplete anti-D. Muratore, Cervelerra, and Cardaci (5) observed a similar phenomenon after injecting guinea pigs with the serum of rabbits previously immunized with guinea pig red cells. In another study, Ovary and Spiegelman (6) noted the development of autohemagglutinins of the cold antibody type in a single rabbit after active immunization with isologous red blood cells.
Antisera:
The anti-chimpanzee red cell grouping reagents capable of detecting isoantigens of chimpanzee red ceUs, prepared as described in a previous study (8) , were sera taken from chimpanzees who had been immunized with human erythrocytes.
The anti-D (R_ho) serum used in these studies was of human origin, produced by specific immunization of a D (Rh0) negative donor. It contained antibodies only of the incomplete variety. The anti-Le . serum, supplied by Dr. James F. Mohn of Buffalo, New York, was a naturally occurring antibody in the serum of an Le(a-) individual.
Three types of antiglobulin sera were employed: (a) rabbit anti-human serum (Coombs' serum), obtained from the Ortho Pharmaceutical Corporation, Raritan, New Jersey; (b) goat anti-chimpanzee serum, prepared by immunization with ammonium sulfate-precipitated globulin fractions of normal chimpanzee serum and appropriately absorbed with normal chimpanzee erythrocytes before use; and (c) anti-human 5'A-, anti-"YG-, anti-5'M,-and anti-~m/fl~A-reagents, obtained from the Hyland Laboratories, Los Angeles, California.
Test cells: Test cells were obtained by collecting 20 ml of whole blood in sterile 30-mi serum vials containing as an anticoagulant 5 ml of ACD solution (acid-citrate-dextrose solution, NIH formula B). The cells were stored at 4°C and used for a period not exceeding 1 week. They were washed three times with copious volumes of cold saline just before use.
Methods.--Immunization schedule: Each animal was immunized with cells from a separate, selected human donor. The leukocyte-red cell mixtures were administered intravenously, while the packed erythrocytes were injected intraperitoneaily. No artificial adjuvants were employed. All inoculations were performed repeatedly at approximately monthly intervals.
Agglutination tests: Agglutination tests for complete antibody were performed by mixing 0.1 mi of a 2 per cent saline suspension of thrice-washed erythrocytes with 0.1 mi of antiserum serially diluted in saline. After incubation for 30 minutes at room temperature (22°C), the tubes were centrifuged for 3 minutes at 600 g and then examined macroscopically for agglutination.
Incomplete antibody was assayed by two techniques. Direct agglutination in colloidal medium was performed using either a serum-albumin mixture consisting of equal parts of normal adult human group AB serum (or in some cases normal adult chimpanzee serum) and 30 per cent bovine albumin (Armour Pharmaceutical Company, Kankakee, Illinois) or normal serum alone as a test cell-suspending medium and diluent for the antiserum. Indirect agglutination was performed according to the standard Coombs' test tube procedure employing any one of a number of the antiglobulin sera. Immediately after addition of the antiglobulin serum, the tubes were centrifuged for 30 seconds in a "serofuge" (Clay Adams) and examined maeroscopically for agglutination.
Absorption procedure: Sera to be absorbed were heat-inactivated at 56°C for 30 minutes and mixed with an equal volume of washed, packed erythrocytes from a single human or chimpanzee donor. After incubation for 15 minutes at room temperature with continuous agitation, the mixture was centrifuged for 10 minutes at 1000 g and the supernatant serum removed. This procedure was repeated until the cells of the individual used for the absorption were no longer agglutinated by the absorbed antisera under the conditions of the test system.
Elution procedure: The heat elution method of Landsteiner and Miller (9) was used to prepare eluted antibody from sensitized ceils. After washing four times with 0.85 per cent saline at 4°C, the ceils were packed by centrifugation for 10 minutes at 1000 g, and the supernatant was saved. The ceils were then resuspended in 1~ their volume of saline and placed in a water-bath at 55°C. After constant agitation in the water-bath for 10 minutes, they were rapidly centrifuged in preheated centrifuge cups and the supernatant quickly removed. Such eluates were always tested on the day of their preparation.
Erythrocyte antibody sensitization tests: In vivo sensitization of erythrocytes by antibody was determined by two procedures. In the direct antiglobulln test, red cells obtained from clotted blood samples were prepared in a 2 per cent saline suspension. Two drops of cell suspension were washed 4 times with 2.5 ml volumes of cold saline solution. After the final wash, the supernatant was discarded, two drops of the appropriate antiglobulin serum were added, and the tubes centrifuged as in the indirect antiglobulin test.
Another procedure employed for this purpose was the adult serum, serum-plus-albumin slide sensitization test of Witebsky (10) . In this method, whole clotted blood was centrifuged and the supernatant serum discarded, after which two drops of packed, unwashed red cells were placed in each of three rings on a premarked slide. Two drops of saline were added to the first ring, two drops of normal adult chimpanzee serum to the second, and two drops of a mixture consisting of equal parts of normal adult chimpanzee serum and 30 per cent bovine albumin to the third. The contents of the rings were mixed, the slide placed on a light-heat view box a~d observed macroscopically for agglutination for 10 minutes. Normal unsensitized cells were always employed as controls.
RESULTS

Detection of the Production of Humoral
Autoagglutinins.--Five of the six chimpanzees were injected with leukocyte-rich human buffy coat and the remaining animal with packed red ceils. One month after the first injection, antibodies were detected in the serum of the erythrocyte-injected animal (Pix) which agglutinated the red cells of all humans. In addition, an agglutinin was produced that reacted with the erythrocytes of 26.6 per cent of the chimpanzees. Based on agglutination tests with this serum, the cells of the animals could thus be divided into two groups: reactors and non-reactors. The production of these agglutinins is the subject of another report (7) .
Sera for testing were drawn from the animals before each injection. At the same time, test ceils were collected from these and other animals being immunized for use as a chimpanzee red cell panel. Curiously enough, during one of these testing procedures, the ceils of two of the originally negative animals (Jethrow and Su) reacted with the Pix antiserum, thereby behaving as reactors. The sera of Jethrow and Su, however, contained an antibody similar to that in the serum of Pix, directed against chimpanzee erythrocyte isoantigens. Up to this point, only non-reactors had been observed to produce this agglutinin. This previous experience made it seem advisable to determine if these animals possessed antibodies in their sera capable of reacting with their own erythrocytes.
When a saline titration for complete antibody was performed in which serial dilutions of each animal's serum were tested against the red cells of the antibody producers, the sera of three of the animals (Bogam, Hari, and Halpha) failed to agglutinate their own erythrocytes (Table I) . On the other hand, the sera of the remaining animals (Pix, Jethrow, and Su) did react with their own cells. Interestingly enough, the Pix serum not only showed a reaction, it displayed a prozone,--thus explaining why Pix was not suspected of exhibiting this phenomenon, i.e. initial screening experiments were performed qualitatively with 1: 2 antiserum dilutions. This saline titration experiment demonstrated the presence of autoagglutinins in the sera of these animals ranging in titer from 32 to 256. The development of these agglutinins along with the species-specific anti-human and chimpanzee iso-specific agglutinins in one of the animals (Jethrow) is depicted in Fig. 1 .
Although these titrations were performed with incubation at room temperature, the antibodies were equally reactive at 37°C. The antibody first appeared in the serum specimen collected 4 weeks after the initial injection and was present in a titer of 32 (log, = 5). It continued to rise slowly, reaching a maximum titer of 128 (log~ = 7), and then dropped off. This animal was somewhat unusual, in that the antibody directed against the chimpanzee isoantigens did not appear until 12 weeks after the initial antigen injection. This was not observed with the other two animals who produced autoagglutinins.
Detection of In Vivo Sensitization of Erytkrocytes.--The serological detection of autoagglutinins in the sera of these animals made it imperative to determine whether red cell sensitization was occurring in vivo.
For this purpose, the erythrocytes of the animals in this group were tested by the direct Coombs' procedure and the adult serum, serum-plus-albumin slide sensitization test of Witebsky. In this experiment, a goat anti-chimpanzee serum absorbed with chimpanzee erythrocytes was employed in various dilutions with the red cells of the animals in this group. 
As shown in Table II , this test yielded strongly positive reactions, even in high antiglobulin serum dilutions, with the cells of Jethrow, Su, and Pix, whereas the reactions with the other three animals were negative. In addition, the erythrocytes of Jethrow, Su, and Pix also displayed positive reactions in the serum portion of the slide sensitization test, although the serum-plus-albumin portion was negative. The erythrocytes of the other three animals were not agglutinated in this test, which was considered to constitute fairly conclusive evidence that the cells of these animals were coated in vivo.
Characteristics of the Coating A gent.--A series of experiments was undertaken to determine possible sensitization of the red cells of these animals by antibody and, if it did exist, its serologic characteristics.
First, a large volume of erythrocytes was collected from each animal in ACD solution for eluate preparation. The elution procedure was followed by means of indirect Coombs' tests, using the goat anti-chimpanzee serum, performed on the cells of both affected and normal animals. Before adding the antiglobulin reagent, the cells were incubated for 60 minutes at 37°C with either saline solution, the final wash solution, or the eluate.
When incubated with saline solution, the cells of Jethrow, Su, and Pix gave a positive antiglobulin reaction before elution and a negative reaction after elution, indicating that the sensitizing agent had been removed from the cells by heating (Table III) . The fact that incubation with the final wash solution 
Hari
Normal untreated ++ yielded a reaction pattern identical with that obtained with saline indicated the absence of humoral components in the system. Incubation with the eluate yielded a positive antiglobulin reaction with the cells of the affected animals and even with the cells of one normal animal (Hari), thus demonstrating the ability of the eluted products to resensitize the erythrocytes from which they were removed. In order to determine the presence of specificity in the products of elution, the eluates were tested against a panel of chimpanzee red cells by the indirect antiglobulin technique. It was desirable to include the cells of the affected animals in this experiment. Although it would have been ideal to use normal cells collected before the onset of autoagglutinin production, this need was not anticipated before immunization procedures were begun, and hence no cells were preserved. (Adequate preservation may have failed anyway under current methods of red cell freezing, because of the fragility of chimpanzee erythrocytes, which we have since noted.) Therefore, we decided to use the sensitized cells after elution. As an adequate control the cells of the normal animals were used both in the native untreated state as well as after subjection to the same elution procedure. Table IV Determination of the immunoglobulin species responsible for the agglutinating activity in the eluate, then, seemed essential. To this end, special eluates were prepared and subjected to immunoelectrophoresis. Even after tenfold concentration, however, insufficient antigenic material was present to show visible bands with the various antisera. Gel diffusion studies in Ouchterlony plates with specific anti-3,A-, anti-3,•-, and anti--3'G-reagents were also unsuccessful.
A method based on the observations of Polley, Mollison, and Soothill (11) and Stratton (12) was tried to establish the immunoglobulin type by indirect means.
Specific antisera to human TA-, To-, and TM-globulins and complement components (obtained from Hyiand Laboratories) were exhaustively absorbed with normal chimpanzee erythrocytes and subsequently used in a direct Coombs' test along with an anti-human serum antiglobulin reagent in order to determine the species of immunoglobulin attached to the red cells in rico. Negative controls for the chimpanzee cells consisted of erythrocytes from immunized but unsensitized animals. Negative controls for the human cells consisted of normal cells, incubated with the specific antisera indicated but lacking the appropriate antigens. This experiment (Table V) made it apparent that the globulin attached to the red cells of these animals was a gamma globulin of the 3'G or 7S variety. In addition, the positive reactions obtained with the anti-/~lc/~lA-reagent suggested the presence of bound complement. Far more desirable, of course, would have been the use of antisera for chimpanzee globulins, but unfortunately such reagents are not yet available. The justification for employing human reagents in testing for chimpanzee globulins stems from the observation of several workers that the antigenic specificities of chimpanzee and human globulins are shared. To demonstrate this, as well as the specificity of the antisera, parallel immunoelectrophoresis of normal human and normal chimpanzee sera was performed using the antiglobulin reagents as indicators. In all four cases tested, the antiglobulin sera reacted identically with the human and the chimpanzee serum components (Fig. 2) .
To determine the globulin nature of the eluted product, an eluate was prepared from the cells of Pix and incubated with the cells of Jethrow, Pix, and Su after elution and those of Hari and Homer for 60 minutes at 37°C. As in previous experiments of this type, the cells of the normal animals (Hari and Homer) were treated at 56°C, like those of Pix, Su, and Jethrow. After sensitization, an indirect antiglobulin test was performed using the specific antiimmunoglobulin reagents. Again, only the anti-'yo-reagent gave a positive result, indicating the eluted antibody to be a gamma globulin of the 7S variety (Table  VI) .
Fie. 2. Immunoelectrophoretograms of chimpanzee (Ch) and human (Hu) sera developed with anti-chimpanzee globulin and anti-human immunoglobulin reagents.
Since it was desirable to relate the autoantibody sensitizing the erythrocytes of these animals to the humoral agglutinins usually found, absorptions of the eluates were performed with human cells as well as positively and negatively reacting chimpanzee cells (Table VII) . The unabsorbed eluate of Pix reacted with all human cells tested as well as those belonging to a group of chimpan-zees represented by the cells of Polly. It failed to react with a number of other chimpanzee cells, such as those of Homer. No sensitizing ability was renmved from the eluate by absorption with Homer's cells. Absorption with Pollv's cells removed only the chimpanzee erythrocyte sensitizing agent, leaving the activity for the human cells intact. Absorption with human cells, however, removed activity for both the human and the chimpanzee red cells from the eluates. 
+++ +++
Seven out of eleven chimpanzees currently being immunized have displayed this phenomenon. Gross hematologic examinations consisting of hemoglobin and hematocrit values, total red cell counts, and peripheral blood smears have revealed no exceptional abnormalities. More refined clinical studies, currently being conducted, will be reported later.
DISCUSSION
While numerous conditions exist under which erythrocytes may yield positive direct-sensitization tests, not all of them can be attributed to the presence of autoantibody in the strict sense. We contend that, in order for this term to be used justifiably, certain criteria must be met.
Foremost among these is recognition of the immunizing antigen. In the present series of experiments the immunizing antigen most likely consisted of human erythrocytes, which, closely defined, of course, represents a heterologous antigen even though there are marked antigenic similarities between the two species. Other reports from our laboratory (7, 8) have shown that immunization of chimpanzees with human red blood cells results in the production of antibodies that react with isoantigens of chimpanzees. Since all of this implies that at least some of the chimpanzee isoantigens are present on human red cells, the immunization in the present study may be regarded as a special type of isoimmunization. From this standpoint, the stimulus for the production of autoantibody could have resulted from the injection of the human cells, a phenomenon essentially similar to that demonstrated by the experiments of Ovary and Spiegelman (6) in which immunization with isologous erythrocytes provoked formation of autoantibody in rabbits.
The second criterion is the establishment of the antibody nature of the sensitizing agent. This, too, is surely a critical factor since during the course of many pathologic conditions either with or without concomitant intrinsic red cell defects, globulin components of various types may become non-specifically attached to the erythrocytes, thereby resulting in positive direct sensitization tests.
That the red cells of the animals in this study were definitely sensitized was clearly demonstrated by the following: elution experiments showed that the sensitizing component could be removed by heat treatment at 56°C, as established by the recovery of a serologically active material and the negative outcome of sensitization tests on the cells after such treatment. The eluate further behaved like antibody in its ability to recombine not only with the red cells after elution but also with certain other normal unsensitized cells.
The negative results of sensitization tests on the red cells after the elution procedure are noteworthy. Although this is a frequent occurrence in this system, complete removal of antibody in some human systems by heat elution, as measured by the Coomb's test, is not possible. When artificially sensitized cells are prepared, the efficiency of antibody dissociation at 56°C seems to be dependent upon the quantity and binding capacity of the agglutinin. It would appear, therefore, that the sensitizing agent in this particular instance does not have an overwhelming affinity for the chimpanzee red cells.
To add additional evidence for the antibody nature of this material, antiglobulin tests were performed with specific sera which showed that this substance was indeed a gamma globulin belonging to the qca class of immunoglobulins. Eluates from sensitized cells could likewise be shown to be composed of a similar substance.
The ultimate proof of the antibody nature of a globulin is the demonstration of specificity. Many globulins can behave as those already described but lacking specificity, thus can not be called antibodies. According to Witebsky (1) , the specificity of antibody is "exquisite" and hence a "non-specific antibody" cannot exist; the two terms are mutually exclusive. The eluates from the sensitized cells of these animals exhibited very definite specificity by reacting with cells of only some of the animals tested. In this way they were quite similar to the circulating antibody usually produced by this type of immunization (7, 8) .
Interestingly enough, the autoantibody eluted from the chimpanzee cells reacted with human cells. It displayed the same cross-reactivity observed previously (7) in that it could be completely absorbed by human cells but not by chimpanzee cells, thus lending further evidence in support of the nature of the immunizing antigen.
These experiments conclusively establish the existence of erythrocyte autoantibodies in the six chimpanzees, although the mechanism of the formation is difficult to explain. At first we felt that it might represent a type of graft versus host reaction, because the phenomenon was first detected in those animals being imraunized with fresh human white cells. It seemed quite possible, that the part of these inocula consisting of approximately 300,000,000 lymphocytes could have contained some viable inmmnologically competent cells which might form clones and produce the antibody. This seemed unlikely, for two reasons: (a) the phenomenon was also observed in animals immunized with essentially pure packed red cells containing only 7050 lymphocytes; and (b) if an immunologically competent human cell were transplanted to a chimpanzee one would expect it to produce antibodies that would react with chimpanzee cells. It would not, however, be expected to produce antibody that would react with all human cells as this one obviously does.
A more plausible explanation seems to lie in the breakdown of immunological tolerance after administration of closely related antigens, as previously" described by Weigle (13) . Although the chimpanzee is presumably tolerant to his own erythrocyte isoantigens, after receiving human red cells, which either share some of these antigens or have antigens closely approximating them chemically or serologically, tolerance is either diminished or totally abolished.
In this same vein, a simpler and perhaps less elegant theory could be evoked, namely, that antibodies produced by an animal to rid itself of invading foreign cells merely cross-react with antigens present on his own cells. This theory is somewhat appealing in that the presence of cross-reacting antibody with poor fit for antigen mav explain why no increased red cell destruction has been observed thus far, even though the erythrocytes seem to be quite heavily sensitized. This fascinating phenoraenon, incidentally, reopens the whole question of whether the autoantibodies in acquired hemolytic anemia are the cause or the effect of the disease process. It also poses a problem concerning the role and action of complement in in vivo red cell destruction mechanisms. In a very indirect manner, our experiments have shown that complement or at least some of its components were surely bound to the sensitized cells. Why, then, they were not destroyed is not understood. It may be that a vital complement component was missing or that the type of antibody (3'G) or its affinity for antigen had some bearing on the eventual fate of the red cells. These points must await further investigation.
SUMMARY
Young adult chimpanzees immunized with human blood products produced circulating antibodies which reacted with human red cells of a certain proportion of chimpanzees. In addition, agglutinins were formed which reacted with the animals' own erythrocytes. That these agglutinins were true autoantibodies was demonstrated by: (a) their ability to sensitize the animals' own erythrocytes at 37°C both in vivo and is vitro; (b) the iso-specificity which they displayed toward other chimpanzee red cells; and (c) the fact that they belonged to the "rG-class of immunoglobulins. Complement appeared to be bound to the is ~/vo sensitized cells but no evidence of increased cell destruction was observed. It seemed most likely that these autoagglutinins were produced as a result of active immunization with closely related antigens.
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